Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic
During COVID-19 outbreak, a large number of children with severe inflammatory disease has been reported. This condition, named Pediatric Multi-inflammatory Syndrome temporally associated with COVID-19 (PIMS-TS) or Multisystem Inflammatory Syndrome associated with Coronavirus Disease 2019 (MIS-C), sh...
Main Authors: | Sara Della Paolera, Erica Valencic, Elisa Piscianz, Valentina Moressa, Alberto Tommasini, Raffaella Sagredini, Valentina Kiren, Manola Comar, Andrea Taddio |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2020.624248/full |
Similar Items
-
Case Report: Changes in Cytokine Kinetics During the Course of Disease in a Japanese Patient With Multisystem Inflammatory Syndrome in Children
by: Satoshi Takasago, et al.
Published: (2021-07-01) -
Pediatric COVID-19 related myocarditis in multisystem inflammatory syndrome: A case report
by: Ririe Fachrina Malisie
Published: (2021-09-01) -
Pediatric Inflammatory Multisystem Syndrome: Statement by the Pediatric Section of the European Society for Emergency Medicine and European Academy of Pediatrics
by: Ruud G. Nijman, et al.
Published: (2020-08-01) -
A child with resistant Kawasaki disease successfully treated with anakinra: a case report
by: J. Sánchez-Manubens, et al.
Published: (2017-04-01) -
Kawasaki disease triggered by parvovirus infection: an atypical case report of two siblings
by: M. C. Maggio, et al.
Published: (2019-04-01)